Factors associated with survival in diabetic patients with rhino-orbito-cerebral mucormycosis

1. Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O. Diabetes and mucormycosis: A complex interplay. Diabetes Metab. 2012;38(3):193-204. DOI: 10.1016/j.diabet.2012.01.002.10.1016/j.diabet.2012.01.002 Search in Google Scholar

2. deShazo RD, O’Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997;123(11):1181-8. DOI: 10.1001/archotol.1997.01900110031005.10.1001/archotol.1997.01900110031005 Search in Google Scholar

3. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am. 2000;33(2):349-65. DOI: 10.1016/s0030-6665(00)80010-9.10.1016/S0030-6665(00)80010-9 Search in Google Scholar

4. Blitzer A, Lawson W, MEYERS BR, Biller HF. Patent survival factor in paransal sinus mucomycosis. Laryngoscope. 1980;90(4):635-48. DOI: 10.1288/00005537-198004000-00010.10.1288/00005537-198004000-00010 Search in Google Scholar

5. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-34. DOI: 10.1093/cid/cir866.10.1093/cid/cir866 Search in Google Scholar

6. Sohail MA, Al Khabori M, Hyder J, Verma A. Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment. Acta Trop. 2001;80(2):177-85. DOI: 10.1016/s0001-706x(01)00174-7.10.1016/S0001-706X(01)00174-7 Search in Google Scholar

7. Meas T, Mouly S, Kania R, Hervé D, Herman P, Kévorkian JP, et al. Zygomycosis: an uncommon cause for peripheral facial palsy in diabetes. Diabetes Metab. 2007;33(3):227-9. DOI: 10.1016/j.diabet.2006.12.001. Epub 2007 Mar 27.10.1016/j.diabet.2006.12.00117392007 Search in Google Scholar

8. Badea C, Sarafoleanu C, Marza A. Rhinosinusal mucormycosis: Literature review and some particular cases. Romanian Journal of Rhinology. 2019;9(35):129-37. DOI: 10.2478/rjr-2019-0015.10.2478/rjr-2019-0015 Search in Google Scholar

9. Hosseini SMS, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262(11):932-8. DOI: 10.1007/s00405-005-0919-0. Epub 2005 May 13.10.1007/s00405-005-0919-015891927 Search in Google Scholar

10. Wiatrak BJ, Willging P, Myer CM 3rd, Cotton RT. Functional endoscopic sinus surgery in the immunocompromised child. Otolaryngol Head Neck Surg. 1991;105(6):818-25. DOI: 10.1177/019459989110500608.10.1177/0194599891105006081787972 Search in Google Scholar

11. Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, et al. Development of new strategies for early diagnosis of mucormycosis from bench to bedside. Mycoses. 2014;57(s3):2-7. DOI: 10.1111/myc.12249.10.1111/myc.12249 Search in Google Scholar

12. Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT. Rhinocerebral mucormycosis: an update. Eur Rev Med Pharmacol Sci. 2010;14(11):987-92. Search in Google Scholar

13. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231-6. Search in Google Scholar

14. Ramírez C, Hernández AF, Méndez V, Trejo S, Contreras R, Espinosa Monteros AL, et al. Mucormicosis en un paciente con agranulocitosis secundaria a metimazol. Informe de un caso. Gac Med Mex. 2009;145(3):235-8. Search in Google Scholar

15. García Insausti C, Majado Martínez MJ, García Hernández AM, Moraleda Jiménez JM. Protocolo diagnóstico de la neutropenia. Med. 2012;11(21):1309-12. DOI: 10.1016/S0304-5412(12)70454-7.10.1016/S0304-5412(12)70454-7 Search in Google Scholar

16. Frey Gutierrez ME, Martínez GW, Alvarez Milán D, Acuña Vassallo JP, Trinajstic EM. Mucormicosis cutanea-presentación de caso clínico, recuerdo de etiopatogenia diagnóstico y tratamiento. Rev la Fac Ciencias Médicas. 2016;73(4):302-5. DOI: 10.31053/1853.0605. v73.n4.15687. Search in Google Scholar

17. Ali A, Abbasi AS, Amjad T, Saleem F. Erythrocyte Sedimentation Rate and C-Reactive Protein as marker of acute versus chronic medical conditions. J Ayub Med Coll Abbottabad. 2019;31(1):39-45. Search in Google Scholar

18. Wu D, Zhang LM, Jiang Y. Clinical features of mucormycosis. Acta Acad Med Sin. 2010;32(4):461-4. Search in Google Scholar

19. Méndez-Tovar LJ, Mejía-Mercado JA, Manzano-Gayosso P, Hernández-Hernández F, López-Martínez R, Silva GI. Frecuencia de micosis invasivas en un hospital mexicano de alta especialidad. Experiencia de 21 años. Rev Med Inst Mex Seguro Soc. 2016;54(5):581-7. Search in Google Scholar

20. Park G, Song SY, Ahn JH, Kim WL, Lee JS, Jeong SY, et al. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiat Oncol. 2019;14(1):116. DOI: 10.1186/s13014-019-1331-z.10.1186/s13014-019-1331-z661089231272506 Search in Google Scholar

21. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27(5):1138-47.10.1093/clinids/27.5.1138 Search in Google Scholar

22. Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, et al. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 2016;16:10. DOI: 10.1186/s12886-016-0189-1.10.1186/s12886-016-0189-1470999726758904 Search in Google Scholar

23. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26-34. DOI: 10.1016/j.cmi.2018.07.011.10.1016/j.cmi.2018.07.01130036666 Search in Google Scholar

24. Jayalakshmi SS, Reddy RG, Borgohain R, Subramanyam C, Panigrahi M, Sundaram C, et al. Predictors of mortality in rhinocerebral mycosis. Neurol India. 2007;55(3):292-7. DOI: 10.4103/0028-3886.35692.10.4103/0028-3886.3569217921660 Search in Google Scholar

25. Corzo-León DE, Chora-Hernández LD, Rodríguez-Zulueta AP, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Med Mycol. 2018;56(1):29-43. DOI: 10.1093/mmy/myx017.10.1093/mmy/myx01728431008 Search in Google Scholar

26. Abdollahi A, Shokohi T, Amirrajab N, Poormosa R, Kasiri A, Motahari SJ, et al. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis: A retrospective analysis. Curr Med Mycol. 2016;2(4):15-23. DOI: 10.18869/acadpub.cmm.2.4.15.10.18869/acadpub.cmm.2.4.15561169228959791 Search in Google Scholar

27. Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127(1):22-31. DOI: 10.1067/mhn.2002.126587.10.1067/mhn.2002.12658712161726 Search in Google Scholar

28. Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: An update. J Infect Public Health. 2012;5(2):116-26. DOI: 10.1016/j.jiph.2012.01.003.10.1016/j.jiph.2012.01.003 Search in Google Scholar

29. Cho HJ, Jang MS, Hong SD, Chung SK, Kim HY, Dhong HJ. Prognostic factors for survival in patients with acute invasive fungal rhinosinusitis. Am J Rhinol Allergy. 2015;29(1):48-53. DOI: 10.2500/ajra.2015.29.4115.10.2500/ajra.2015.29.4115 Search in Google Scholar

30. Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22(9):810. e1-810.e8. DOI: 10.1016/j.cmi.2015.12.006.10.1016/j.cmi.2015.12.006 Search in Google Scholar

31. Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis. 2011;11(4):301-11. DOI: 10.1016/S1473-3099(10)70316-9.10.1016/S1473-3099(10)70316-9 Search in Google Scholar

32. McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150-160. DOI: 10.1056/NEJMra1216008.10.1056/NEJMra1216008484046125006721 Search in Google Scholar

33. Jung SH, Kim SW, Park CS, Song CE, Cho JH, Lee JH, et al. Rhino-cerebral Mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx. 2009;36(3):274-9. DOI: 10.1016/j.anl.2008.07.003. Epub 2008 Sep 10.10.1016/j.anl.2008.07.00318786790 Search in Google Scholar

34. Chan LL, Singh S, Jones D, Diaz EM, Ginsberg LE. Imaging of mucormycosis skull base osteomyelitis. AJNR Am J Neuroradiol. 2000;21(5):828-31. Search in Google Scholar

35. Gamba JL, Woodruff WW, Djang WT, Yeates AE. Cranofacial mucormycosis: assessment with CT. Radiology. 1986;160(1):207-12. DOI: 10.1148/radiology.160.1.3715034.10.1148/radiology.160.1.37150343715034 Search in Google Scholar

36. Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthalmic Plast Reconstr Surg. 2006;22(4):286-91. DOI: 10.1097/01. iop.0000225418.50441.ee.10.1097/01 Search in Google Scholar

37. Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2019;103(10):1460-5. DOI: 10.1136/bjophthalmol-2018-312688.10.1136/bjophthalmol-2018-31268830514712 Search in Google Scholar